Month: September 2022

Prestigious list honoring the logistics industry’s most innovative companies includes GXO for a second consecutive year GREENWICH, Conn., Sept. 21, 2022 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has been named by FreightWaves as one of the FreightTech 100 for the second consecutive year. Freightwaves, the industry-leading provider of news, data and analytics for the logistics markets, created the FreightTech 100 to spotlight the most innovative companies in the industry. “As a company dedicated to helping customers optimize their warehouse fulfillment operations through innovation, GXO is honored to receive this recognition from FreightWaves,” said Sandeep Sakharkar, Chief Information Officer, GXO. “We’re heading into the peak season,...

BOSTON and LOUISVILLE, Ky., Sept. 21, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at William Blair’s Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event on Wednesday, September 28, 2022 at 1:00 PM ET. A live webcast of the presentation will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, the event will remain archived on the Talaris website for 30 days. About Talaris TherapeuticsTalaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing...

Treatment with CNM-Au8 significantly improved long-term survival with approximately a 70% decreased risk of mortality vs. original placebo randomization Comparable survival benefits were also shown compared to ENCALS predicted median survival CNM-Au8 treatment was well-tolerated, and there were no significant safety findings reportedSALT LAKE CITY, Sept. 21, 2022 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, today announced presentation of updated survival results from the Phase 2 RESCUE-ALS trial open-label extension (OLE) at the 2022 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Clinical...

TomaGold Corporation TomaGold takes strategic position in the lithium sectorMONTREAL, Sept. 21, 2022 (GLOBE NEWSWIRE) — TOMAGOLD CORPORATION (TSXV: LOT) (OTCQB: TOGOF) (“TomaGold” or the “Corporation”) is pleased to announce the acquisition of a 100% interest in 38 claims from Noranda Royalties and the acquisition of 69 map-designated claims covering a total area of 5,487.52 ha (or 55 km2). These claims are located near Zones 1, 2, 3 and 6 of the James Bay Lithium Brisk project optioned by Monger Gold and along and south of the Trans-Taiga regional road and power line infrastructure, approximately 5 km from the LG-3 airport. These claims are also located on the same geological corridor as the Cancet (5.6% Li2O over 36.5 m) and Corvette (1.65% Li2O over 159.7 m) projects, held by Winsome Resources and Patriot Battery Metals...

Issuance of Anavex’s Newest U.S. Patent Will Expand Anavex’s Intellectual Property Portfolio Surrounding ANAVEX®2-73 NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced that United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,446,275 to Anavex, with claims to treatment methods using its leading drug candidate, ANAVEX®2-73 (blarcamesine) and its analogs, for ameliorating biochemical and functional abnormalities associated with methyl-CpG binding protein 2 defects...

VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) — ParcelPal Logistics Inc. (the “Company” or “ParcelPal”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0A) is pleased to announce that it is endeavoring to retain a full time CFO given the Company’s recent expansion in the Western United States and with the growth and diversification of its customer base and operations. CEO Rich Wheeless stated, “Since I joined the Company in March 2020, we have grown our customer base and geographic operations. During this period, I have continued in the interim CFO position; however, we have determined that our growth and scope of operations now calls for the retention of added executive management strength in order to efficiently and effectively manage our Company in order to continue to grow and execute on additional milestones that we have laid...

Research Examines Regional Workforce Background Screening and Risk Management MEXICO CITY, Sept. 21, 2022 (GLOBE NEWSWIRE) — First Advantage – MultiLatin, a regional division of First Advantage Corporation (NASDAQ: FA), a leading global provider of HR technology solutions for screening, verifications, safety and compliance, today announced the availability of its Latin America (LATAM) 2022 Annual Trends Report. The report reveals illuminating regional perspectives on background screening trends throughout 2021 and the direct correlation to risk management.  According to the annual survey, 38 percent of respondents say they conduct background screens on job applicants to help minimize risk, followed by 27 percent to fill regulatory compliance, 17 percent to ensure applicants have the right qualifications for the role, and 6 percent...